Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Janine Kimpel

Medical University of Innsbruck

Austria

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

90%

Virology

100%

Sars-cov-2

90%

Immune Response

50%

Vaccinology

50%

Covid-19

40%

Immunotherapy

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles18

Durability of Cross-Neutralizing Antibodies 5.5 Months After Bivalent Coronavirus Disease 2019 Vaccine Booster

Article Link

Year:

2024

A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories

Article Link

Year:

2024

Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography

Article Link

Year:

2023

No evidence for epitranscriptomic m5C modification of SARS-CoV-2, HIV and MLV viral RNA

Article Link

Year:

2023

Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination.

Article Link

Year:

2023

B and T Cell Responses to SARS-CoV-2 Vaccination in Kidney and Liver Transplant Recipients with and without Previous COVID-19

Article Link

Year:

2023

Antiviral Potential of Azelastine against Major Respiratory Viruses

Article Link

Year:

2023

Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial.

Article Link

Year:

2023

Therapeutic Efficacy of a VSV-GP-based Human Papilloma Virus Vaccine in a Murine Cancer Model.

Article Link

Year:

2023

Regimen of Coronavirus Disease 2019 Vaccination Influences Extent and Kinetics of Antibody Avidity

Article Link

Year:

2022

High Prevalence of Undocumented SARS-CoV-2 Infections in the Pediatric Population of the Tyrolean District of Schwaz

Article Link

Year:

2022

Can high COVID-19 vaccination rates in adults help protect unvaccinated children? Evidence from a unique mass vaccination campaign, Schwaz/Austria, March 2021

Article Link

Year:

2022

Six-Month Follow-Up of Immune Responses after a Rapid Mass Vaccination against SARS-CoV-2 with BNT162b2 in the District of Schwaz/Austria

Article Link

Year:

2022

The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue.

Article Link

Year:

2022

Development of a Rapid Live SARS-CoV-2 Neutralization Assay Based on a qPCR Readout.

Article Link

Year:

2022

Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection

Article Link

Year:

2022

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons

Article Link

Year:

2022

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants

Article Link

Year:

2022

Collaborators8

Volker Thiel

Professor and Chair Virology

University of Bern

SWITZERLAND

Giada Mattiuzzo

Head of Viral Vaccines

Pharmaceuticals and Medical Devices Agency

UNITED KINGDOM

Reinhard Würzner

Associate Professor

Medical University of Innsbruck

AUSTRIA

Bart L. Haagmans

Principal Investigator / Associate Professor - PhD

Erasmus MC

NETHERLANDS

Wegene Borena

Medical University of Innsbruck

AUSTRIA

Zoltan Banki

Medical University of Innsbruck

AUSTRIA

Derek Smith

Professor of Infectious Disease Informatics

University of Cambridge

UNITED KINGDOM

Annika Rössler

University of Innsbruck

AUSTRIA

How do I reach out?

Meet Kite AI